Tweet
<img alt="" height="1" width="1" />
NICE Blocks NHS Use Of Glaxo Blood Platelet Booster Revolade
Wall Street Journal
LONDON (Dow Jones)--The UK's National Institute for Health and Clinical Excellence, or NICE, Thursday said it won't recommend publicly-funded use of GlaxoSmithKline PLC's (GSK) Revolade drug for treatment of a rare blood clotting disorder that can ...
Glaxo platelet drug rejected by UK cost agencyReuters
UK recommends against buying breast cancer drugThe Associated Press
Cancer advances may be more significant than they seemSeattle Times
Financial Times -Cancer Research UK -Investor's Business Daily
all 105 news articles »
More...